<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34196307</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>13</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Neurodegenerative disorders and gut-brain interactions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e143775</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI143775</ELocationID><Abstract><AbstractText>Neurodegenerative disorders (NDs) affect essential functions not only in the CNS, but also cause persistent gut dysfunctions, suggesting that they have an impact on both CNS and gut-innervating neurons. Although the CNS biology of NDs continues to be well studied, how gut-innervating neurons, including those that connect the gut to the brain, are affected by or involved in the etiology of these debilitating and progressive disorders has been understudied. Studies in recent years have shown how CNS and gut biology, aided by the gut-brain connecting neurons, modulate each other's functions. These studies underscore the importance of exploring the gut-innervating and gut-brain connecting neurons of the CNS and gut function in health, as well as the etiology and progression of dysfunction in NDs. In this Review, we discuss our current understanding of how the various gut-innervating neurons and gut physiology are involved in the etiology of NDs, including Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis, to cause progressive CNS and persistent gut dysfunction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Alpana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Neurogastroenterology, Division of Gastroenterology and Hepatology, Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawson</LastName><ForeName>Ted M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Solomon H. Snyder Department of Neuroscience, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adrienne Helis Malvin Medical Research Foundation, New Orleans, Louisiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>Subhash</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Neurogastroenterology, Division of Gastroenterology and Hepatology, Department of Medicine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 NS038377</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG066768</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004064" MajorTopicYN="N">Digestive System</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="N">innervation</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017615" MajorTopicYN="N">Enteric Nervous System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> TMD has received personal compensation as a consultant for Sun Pharma Advanced Research Company; is a member of the advisory board of American Gene Technologies International Inc.; and is a consultant for Mitokinin and Inhibikase Therapeutics Inc. TMD is compensated for his roles as a consultant for and interim chief scientific officer of Valted Seq Inc., and his spouse serves on the board of directors and is compensated for her role as interim CEO of Valted Seq Inc. TMD was a paid consultant to and advisory board member of DONG-A ST and has received personal compensation for consulting and serving on the scientific advisory board of Hopstem Inc. TMD owns stock options in American Gene Technologies International Inc., Mitokinin, and Inhibikase Therapeutics Inc. TMD is a founder of Valted LLC and holds an ownership equity interest in the company. TMD is an inventor of technology for Neuraly Inc. that has been optioned from Johns Hopkins University. TMD and his spouse are founders of and hold shares of stock as well as equity in Neuraly Inc., which is now a subsidiary of D&amp;D Pharmatech. TMD and his spouse hold shares of stock as well as equity in D&amp;D Pharmatech. TMD and his spouse are founders of and hold equity in Valted Seq Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>8</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34196307</ArticleId><ArticleId IdType="pmc">PMC8245172</ArticleId><ArticleId IdType="doi">10.1172/JCI143775</ArticleId><ArticleId IdType="pii">e143775</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martin JB. Molecular basis of the neurodegenerative disorders. N Engl J Med. 1999;340(25):1970&#x2013;1980. doi: 10.1056/NEJM199906243402507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199906243402507</ArticleId><ArticleId IdType="pubmed">10379022</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey ER, et al. The coming crisis: obtaining care for the growing burden of neurodegenerative conditions. Neurology. 2013;80(21):1989&#x2013;1996. doi: 10.1212/WNL.0b013e318293e2ce.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318293e2ce</ArticleId><ArticleId IdType="pmc">PMC3716348</ArticleId><ArticleId IdType="pubmed">23616157</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7):a028035. doi: 10.1101/cshperspect.a028035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028035</ArticleId><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenberg A, et al. The &#x201c;institutional colon&#x201d;: a frequent colonic dysmotility in psychiatric and neurologic disease. Am J Gastroenterol. 1994;89(1):62&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">8273800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtishi A, et al. Cellular proteostasis in neurodegeneration. Mol Neurobiol. 2019;56(5):3676&#x2013;3689. doi: 10.1007/s12035-018-1334-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1334-z</ArticleId><ArticleId IdType="pubmed">30182337</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury JJ, et al. Walking the tightrope: proteostasis and neurodegenerative disease. J Neurochem. 2016;137(4):489&#x2013;505. doi: 10.1111/jnc.13575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13575</ArticleId><ArticleId IdType="pubmed">26872075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi J, et al. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics. Rev Neurosci. 2019;30(4):339&#x2013;358. doi: 10.1515/revneuro-2016-0035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2016-0035</ArticleId><ArticleId IdType="pubmed">30742586</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332&#x2013;1340. doi: 10.1038/s41593-018-0235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0235-9</ArticleId><ArticleId IdType="pmc">PMC6432913</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney P, et al. Protein misfolding in neurodegenerative diseases: implications and strategies. Transl Neurodegener. 2017;6:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5348787</ArticleId><ArticleId IdType="pubmed">28293421</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao G, et al. Ubiquitin-proteasome system in neurodegenerative disorders. J Drug Metab Toxicol. 2015;6(4):187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6370320</ArticleId><ArticleId IdType="pubmed">30761219</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinnon C, Tabrizi SJ. The ubiquitin-proteasome system in neurodegeneration. Antioxid Redox Signal. 2014;21(17):2302&#x2013;2321. doi: 10.1089/ars.2013.5802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5802</ArticleId><ArticleId IdType="pubmed">24437518</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda N, Tanaka K. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson&#x2019;s disease? J Alzheimers Dis. 2010;19(1):1&#x2013;9. doi: 10.3233/JAD-2010-1231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-1231</ArticleId><ArticleId IdType="pubmed">20061621</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson TM. Parkin and defective ubiquitination in Parkinson&#x2019;s disease. J Neural Transm Suppl. 2006;(70):209&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">17017531</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer&#x2019;s disease. Rev Neurosci. 2017;28(8):861&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pubmed">28704199</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco A, Fraldi A. Protein aggregation and dysfunction of autophagy-lysosomal pathway: a vicious cycle in lysosomal storage diseases. Front Mol Neurosci. 2020;13:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079699</ArticleId><ArticleId IdType="pubmed">32218723</ArticleId></ArticleIdList></Reference><Reference><Citation>Darios F, Stevanin G. Impairment of lysosome function and autophagy in rare neurodegenerative diseases. J Mol Biol. 2020;432(8):2714&#x2013;2734. doi: 10.1016/j.jmb.2020.02.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.02.033</ArticleId><ArticleId IdType="pmc">PMC7232018</ArticleId><ArticleId IdType="pubmed">32145221</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik BR, et al. Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Mol Brain. 2019;12(1):100. doi: 10.1186/s13041-019-0504-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0504-x</ArticleId><ArticleId IdType="pmc">PMC6884906</ArticleId><ArticleId IdType="pubmed">31783880</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh JY, et al. Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc. Mol Brain. 2019;12(1):18. doi: 10.1186/s13041-019-0439-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0439-2</ArticleId><ArticleId IdType="pmc">PMC6417073</ArticleId><ArticleId IdType="pubmed">30866990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, et al. Endo-lysosomal dysfunction: a converging mechanism in neurodegenerative diseases. Curr Opin Neurobiol. 2018;48:52&#x2013;58. doi: 10.1016/j.conb.2017.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2017.09.005</ArticleId><ArticleId IdType="pubmed">29028540</ArticleId></ArticleIdList></Reference><Reference><Citation>Usenovic M, Krainc D. Lysosomal dysfunction in neurodegeneration: the role of ATP13A2/PARK9. Autophagy. 2012;8(6):987&#x2013;988. doi: 10.4161/auto.20256.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.20256</ArticleId><ArticleId IdType="pmc">PMC3427268</ArticleId><ArticleId IdType="pubmed">22561922</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, et al. The lysosome and neurodegenerative diseases. Acta Biochim Biophys Sin (Shanghai) 2009;41(6):437&#x2013;445. doi: 10.1093/abbs/gmp031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmp031</ArticleId><ArticleId IdType="pubmed">19499146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim GH, et al. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24(4):325&#x2013;340. doi: 10.5607/en.2015.24.4.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.4.325</ArticleId><ArticleId IdType="pmc">PMC4688332</ArticleId><ArticleId IdType="pubmed">26713080</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedzielska E, et al. Oxidative stress in neurodegenerative diseases. Mol Neurobiol. 2016;53(6):4094&#x2013;4125. doi: 10.1007/s12035-015-9337-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9337-5</ArticleId><ArticleId IdType="pmc">PMC4937091</ArticleId><ArticleId IdType="pubmed">26198567</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, et al. Oxidative stress in neurodegenerative diseases. Neural Regen Res. 2012;7(5):376&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4350122</ArticleId><ArticleId IdType="pubmed">25774178</ArticleId></ArticleIdList></Reference><Reference><Citation>Uttara B, et al. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65&#x2013;74. doi: 10.2174/157015909787602823.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015909787602823</ArticleId><ArticleId IdType="pmc">PMC2724665</ArticleId><ArticleId IdType="pubmed">19721819</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrell J, et al. A mutation in the amyloid precursor protein associated with hereditary Alzheimer&#x2019;s disease. Science. 1991;254(5028):97&#x2013;99. doi: 10.1126/science.1925564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1925564</ArticleId><ArticleId IdType="pubmed">1925564</ArticleId></ArticleIdList></Reference><Reference><Citation>Saffert P, et al. An expanded CAG repeat in huntingtin causes +1 frameshifting. J Biol Chem. 2016;291(35):18505&#x2013;18513. doi: 10.1074/jbc.M116.744326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.744326</ArticleId><ArticleId IdType="pmc">PMC5000095</ArticleId><ArticleId IdType="pubmed">27382061</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehhaghi M, et al. Microorganisms&#x2019; footprint in neurodegenerative diseases. Front Cell Neurosci. 2018;12:466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288487</ArticleId><ArticleId IdType="pubmed">30564101</ArticleId></ArticleIdList></Reference><Reference><Citation>De Chiara G, et al. Infectious agents and neurodegeneration. Mol Neurobiol. 2012;46(3):614&#x2013;638. doi: 10.1007/s12035-012-8320-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-012-8320-7</ArticleId><ArticleId IdType="pmc">PMC3496540</ArticleId><ArticleId IdType="pubmed">22899188</ArticleId></ArticleIdList></Reference><Reference><Citation>Sochocka M, et al. The gut microbiome alterations and inflammation-driven pathogenesis of alzheimer&#x2019;s disease-a critical review. Mol Neurobiol. 2019;56(3):1841&#x2013;1851. doi: 10.1007/s12035-018-1188-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1188-4</ArticleId><ArticleId IdType="pmc">PMC6394610</ArticleId><ArticleId IdType="pubmed">29936690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni S, et al. Neuro-innate immune interactions in gut mucosal immunity. Curr Opin Immunol. 2020;68:64&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">33130386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni S, et al. Advances in enteric neurobiology: the &#x201c;brain&#x201d; in the gut in health and disease. J Neurosci. 2018;38(44):9346&#x2013;9354. doi: 10.1523/JNEUROSCI.1663-18.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1663-18.2018</ArticleId><ArticleId IdType="pmc">PMC6209840</ArticleId><ArticleId IdType="pubmed">30381426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni S, et al. Adult enteric nervous system in health is maintained by a dynamic balance between neuronal apoptosis and neurogenesis. Proc Natl Acad Sci U S A. 2017;114(18):E3709&#x2013;E3718. doi: 10.1073/pnas.1619406114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1619406114</ArticleId><ArticleId IdType="pmc">PMC5422809</ArticleId><ArticleId IdType="pubmed">28420791</ArticleId></ArticleIdList></Reference><Reference><Citation>Furness JB, Stebbing MJ. The first brain: Species comparisons and evolutionary implications for the enteric and central nervous systems. Neurogastroenterol Motil. 2018;30(2):e13234</Citation><ArticleIdList><ArticleId IdType="pubmed">29024273</ArticleId></ArticleIdList></Reference><Reference><Citation>Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9(5):286&#x2013;294. doi: 10.1038/nrgastro.2012.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2012.32</ArticleId><ArticleId IdType="pubmed">22392290</ArticleId></ArticleIdList></Reference><Reference><Citation>Travagli RA, Anselmi L. Vagal neurocircuitry and its influence on gastric motility. Nat Rev Gastroenterol Hepatol. 2016;13(7):389&#x2013;401. doi: 10.1038/nrgastro.2016.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2016.76</ArticleId><ArticleId IdType="pmc">PMC5605144</ArticleId><ArticleId IdType="pubmed">27251213</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackeim HA, et al. The long and winding road of vagus nerve stimulation: challenges in developing an intervention for difficult-to-treat mood disorders. Neuropsychiatr Dis Treat. 2020;16:3081&#x2013;3093. doi: 10.2147/NDT.S286977.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S286977</ArticleId><ArticleId IdType="pmc">PMC7751788</ArticleId><ArticleId IdType="pubmed">33364761</ArticleId></ArticleIdList></Reference><Reference><Citation>Browning KN, et al. The vagus nerve in appetite regulation, mood, and intestinal inflammation. Gastroenterology. 2017;152(4):730&#x2013;744. doi: 10.1053/j.gastro.2016.10.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.10.046</ArticleId><ArticleId IdType="pmc">PMC5337130</ArticleId><ArticleId IdType="pubmed">27988382</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, et al. Transient gastric irritation in the neonatal rats leads to changes in hypothalamic CRF expression, depression- and anxiety-like behavior as adults. PLoS One. 2011;6(5):e19498. doi: 10.1371/journal.pone.0019498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0019498</ArticleId><ArticleId IdType="pmc">PMC3093391</ArticleId><ArticleId IdType="pubmed">21589865</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookes S, et al. Extrinsic sensory innervation of the gut: structure and function. Adv Exp Med Biol. 2016;891:63&#x2013;69. doi: 10.1007/978-3-319-27592-5_7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-27592-5_7</ArticleId><ArticleId IdType="pubmed">27379635</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai NY, et al. Gut-innervating nociceptor neurons regulate peyer&#x2019;s patch microfold cells and sfb levels to mediate salmonella host defense. Cell. 2020;180(1):33&#x2013;49. doi: 10.1016/j.cell.2019.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.11.014</ArticleId><ArticleId IdType="pmc">PMC6954329</ArticleId><ArticleId IdType="pubmed">31813624</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller PA, et al. Microbiota modulate sympathetic neurons via a gut-brain circuit. Nature. 2020;583(7816):441&#x2013;446. doi: 10.1038/s41586-020-2474-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2474-7</ArticleId><ArticleId IdType="pmc">PMC7367767</ArticleId><ArticleId IdType="pubmed">32641826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamm MA, et al. Sacral nerve stimulation for intractable constipation. Gut. 2010;59(3):333&#x2013;340. doi: 10.1136/gut.2009.187989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2009.187989</ArticleId><ArticleId IdType="pubmed">20207638</ArticleId></ArticleIdList></Reference><Reference><Citation>Preziosi G, et al. Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies. Degener Neurol Neuromuscul Dis. 2018;8:79&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6287516</ArticleId><ArticleId IdType="pubmed">30584387</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofei SY, et al. Constipation burden in children with autism spectrum disorder: emergency department and healthcare use. J Pediatr. 2018;202:12&#x2013;13. doi: 10.1016/j.jpeds.2018.06.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2018.06.057</ArticleId><ArticleId IdType="pubmed">30025674</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauerbier A, Ray Chaudhuri K. Non-motor symptoms: the core of multi-morbid Parkinson&#x2019;s disease. Br J Hosp Med (Lond) 2014;75(1):18&#x2013;24. doi: 10.12968/hmed.2014.75.1.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/hmed.2014.75.1.18</ArticleId><ArticleId IdType="pubmed">24401966</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu A. Neostigmine: an alternative treatment for constipation. Dynamics. 2005;16(1):13&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">15835453</ArticleId></ArticleIdList></Reference><Reference><Citation>Penzol MJ, et al. Functional gastrointestinal disease in autism spectrum disorder: a retrospective descriptive study in a clinical sample. Front Psychiatry. 2019;10:179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6469513</ArticleId><ArticleId IdType="pubmed">31024351</ArticleId></ArticleIdList></Reference><Reference><Citation>Heetun ZS, Quigley EM. Gastroparesis and Parkinson&#x2019;s disease: a systematic review. Parkinsonism Relat Disord. 2012;18(5):433&#x2013;440. doi: 10.1016/j.parkreldis.2011.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2011.12.004</ArticleId><ArticleId IdType="pubmed">22209346</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies GA, et al. Prion diseases and the gastrointestinal tract. Can J Gastroenterol. 2006;20(1):18&#x2013;24. doi: 10.1155/2006/184528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2006/184528</ArticleId><ArticleId IdType="pmc">PMC2538961</ArticleId><ArticleId IdType="pubmed">16432555</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M, et al. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1(1):15&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">12365061</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasser CI, et al. Gut dysbiosis in Huntington&#x2019;s disease: associations among gut microbiota, cognitive performance and clinical outcomes. Brain Commun. 2020;2(2):fcaa110. doi: 10.1093/braincomms/fcaa110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa110</ArticleId><ArticleId IdType="pmc">PMC7519724</ArticleId><ArticleId IdType="pubmed">33005892</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallen ZD, et al. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis. 2020;6:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7293233</ArticleId><ArticleId IdType="pubmed">32566740</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotkine M, et al. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect. Gut Microbes. 2020;11(6):1833&#x2013;1841. doi: 10.1080/19490976.2020.1767464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1767464</ArticleId><ArticleId IdType="pmc">PMC7524331</ArticleId><ArticleId IdType="pubmed">32501768</ArticleId></ArticleIdList></Reference><Reference><Citation>Schepici G, et al. The gut microbiota in multiple sclerosis: an overview of clinical trials. Cell Transplant. 2019;28(12):1507&#x2013;1527. doi: 10.1177/0963689719873890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689719873890</ArticleId><ArticleId IdType="pmc">PMC6923550</ArticleId><ArticleId IdType="pubmed">31512505</ArticleId></ArticleIdList></Reference><Reference><Citation>Fattorusso A, et al. Autism spectrum disorders and the gut microbiota. Nutrients. 2019;11(3):E521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6471505</ArticleId><ArticleId IdType="pubmed">30823414</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SC, et al. Intestinal microbial dysbiosis aggravates the progression of Alzheimer&#x2019;s disease in Drosophila. Nat Commun. 2017;8(1):24. doi: 10.1038/s41467-017-00040-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00040-6</ArticleId><ArticleId IdType="pmc">PMC5478647</ArticleId><ArticleId IdType="pubmed">28634323</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson DS, Mabbott NA. The influence of the commensal and pathogenic gut microbiota on prion disease pathogenesis. J Gen Virol. 2016;97(8):1725&#x2013;1738. doi: 10.1099/jgv.0.000507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000507</ArticleId><ArticleId IdType="pubmed">27193137</ArticleId></ArticleIdList></Reference><Reference><Citation>Surmeier DJ, et al. What causes the death of dopaminergic neurons in Parkinson&#x2019;s disease? Prog Brain Res. 2010;183:59&#x2013;77. doi: 10.1016/S0079-6123(10)83004-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0079-6123(10)83004-3</ArticleId><ArticleId IdType="pubmed">20696315</ArticleId></ArticleIdList></Reference><Reference><Citation>DauerW, Przedborski S. Parkinson&#x2019;s disease: mechanisms and models. Neuron. 2003;39(6):889&#x2013;909. doi: 10.1016/S0896-6273(03)00568-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(03)00568-3</ArticleId><ArticleId IdType="pubmed">12971891</ArticleId></ArticleIdList></Reference><Reference><Citation>Przedborski S. The two-century journey of Parkinson disease research. Nat Rev Neurosci. 2017;18(4):251&#x2013;259. doi: 10.1038/nrn.2017.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.25</ArticleId><ArticleId IdType="pubmed">28303016</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich SG. Diagnosing Parkinson&#x2019;s disease. In: Reich SG, Factor SA, eds. Therapy of Movement Disorders: A Case-Based Approach. Springer; 2019:3&#x2013;6.</Citation></Reference><Reference><Citation>de Lau LML, Breteler MMB. Epidemiology of Parkinson&#x2019;s disease. Lancet Neurol. 2006;5(6):525&#x2013;535. doi: 10.1016/S1474-4422(06)70471-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(06)70471-9</ArticleId><ArticleId IdType="pubmed">16713924</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, et al. Staging of brain pathology related to sporadic Parkinson&#x2019;s disease. Neurobiol Aging. 2003;24(2):197&#x2013;211. doi: 10.1016/S0197-4580(02)00065-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(02)00065-9</ArticleId><ArticleId IdType="pubmed">12498954</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Le W. Milestones of Parkinson&#x2019;s disease research: 200 years of history and beyond. Neurosci Bull. 2017;33(5):598&#x2013;602. doi: 10.1007/s12264-017-0178-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-017-0178-2</ArticleId><ArticleId IdType="pmc">PMC5636740</ArticleId><ArticleId IdType="pubmed">28895075</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, et al. 100 years of Lewy pathology. Nat Rev Neurol. 2013;9(1):13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">23183883</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanis L. &#x3b1;-Synuclein in Parkinson&#x2019;s disease. Cold Spring Harb Perspect Med. 2012;2(2):a009399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281589</ArticleId><ArticleId IdType="pubmed">22355802</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas JY, et al. The prion-like spreading of &#x3b1;-synuclein: From in vitro to in vivo models of Parkinson&#x2019;s disease. Ageing Res Rev. 2019;50:89&#x2013;101. doi: 10.1016/j.arr.2019.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2019.01.012</ArticleId><ArticleId IdType="pubmed">30690184</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahmoradian SH, et al. Lewy pathology in Parkinson&#x2019;s disease consists of crowded organelles and lipid membranes. Nat Neurosci. 2019;22(7):1099&#x2013;1109. doi: 10.1038/s41593-019-0423-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0423-2</ArticleId><ArticleId IdType="pubmed">31235907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia LV, Kalia SK. &#x3b1;-Synuclein and Lewy pathology in Parkinson&#x2019;s disease. Curr Opin Neurol. 2015;28(4):375&#x2013;381. doi: 10.1097/WCO.0000000000000215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000215</ArticleId><ArticleId IdType="pubmed">26110807</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K, et al. Parkinson&#x2019;s disease: the presence of Lewy bodies in Auerbach&#x2019;s and Meissner&#x2019;s plexuses. Acta Neuropathol. 1988;76(3):217&#x2013;221. doi: 10.1007/BF00687767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00687767</ArticleId><ArticleId IdType="pubmed">2850698</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupsky WJ, et al. Parkinson&#x2019;s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology. 1987;37(7):1253&#x2013;1255. doi: 10.1212/WNL.37.7.1253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.37.7.1253</ArticleId><ArticleId IdType="pubmed">3037441</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, et al. Staging of brain pathology related to sporadic Parkinson&#x2019;s disease. Neurobiol Aging. 2003;24(2):197&#x2013;211. doi: 10.1016/S0197-4580(02)00065-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(02)00065-9</ArticleId><ArticleId IdType="pubmed">12498954</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, et al. Gastric alpha-synuclein immunoreactive inclusions in Meissner&#x2019;s and Auerbach&#x2019;s plexuses in cases staged for Parkinson&#x2019;s disease-related brain pathology. Neurosci Lett. 2006;396(1):67&#x2013;72. doi: 10.1016/j.neulet.2005.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2005.11.012</ArticleId><ArticleId IdType="pubmed">16330147</ArticleId></ArticleIdList></Reference><Reference><Citation>Stirpe P, et al. Constipation: an emerging risk factor for Parkinson&#x2019;s disease? Eur J Neurol. 2016;23(11):1606&#x2013;1613. doi: 10.1111/ene.13082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13082</ArticleId><ArticleId IdType="pubmed">27444575</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott RD, et al. Frequency of bowel movements and the future risk of Parkinson&#x2019;s disease. Neurology. 2001;57(3):456&#x2013;462. doi: 10.1212/WNL.57.3.456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.3.456</ArticleId><ArticleId IdType="pubmed">11502913</ArticleId></ArticleIdList></Reference><Reference><Citation>Savica R, et al. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology. 2009;73(21):1752&#x2013;1758. doi: 10.1212/WNL.0b013e3181c34af5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c34af5</ArticleId><ArticleId IdType="pmc">PMC2788809</ArticleId><ArticleId IdType="pubmed">19933976</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams-Carr KL, et al. Constipation preceding Parkinson&#x2019;s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2015;87(7):710&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">26345189</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu P, et al. Association of intestinal disorders with Parkinson&#x2019;s disease and Alzheimer&#x2019;s disease: a systematic review and meta-analysis. ACS Chemical Neuroscience. 2020;11(3):395&#x2013;405. doi: 10.1021/acschemneuro.9b00607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.9b00607</ArticleId><ArticleId IdType="pubmed">31876406</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson E, et al. Vagotomy and subsequent risk of Parkinson&#x2019;s disease. Ann Neurol. 2015;78(4):522&#x2013;529. doi: 10.1002/ana.24448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24448</ArticleId><ArticleId IdType="pubmed">26031848</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, et al. Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study. Neurology. 2017;88(21):1996&#x2013;2002. doi: 10.1212/WNL.0000000000003961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003961</ArticleId><ArticleId IdType="pmc">PMC5440238</ArticleId><ArticleId IdType="pubmed">28446653</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson&#x2019;s disease rats. Transl Res. 2015;166(2):152&#x2013;162. doi: 10.1016/j.trsl.2015.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2015.02.003</ArticleId><ArticleId IdType="pubmed">25766133</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu HC, et al. Gastrointestinal dysfunction in a Parkinson&#x2019;s disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus. J Mol Neurosci. 2012;47(1):15&#x2013;25. doi: 10.1007/s12031-011-9560-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9560-0</ArticleId><ArticleId IdType="pmc">PMC3338324</ArticleId><ArticleId IdType="pubmed">21647710</ArticleId></ArticleIdList></Reference><Reference><Citation>Anselmi L, et al. Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat. NPJ Parkinsons Dis. 2018;4:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6160447</ArticleId><ArticleId IdType="pubmed">30302391</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmqvist S, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128(6):805&#x2013;820. doi: 10.1007/s00401-014-1343-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1343-6</ArticleId><ArticleId IdType="pubmed">25296989</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredsson FP, et al. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis. 2018;112:106&#x2013;118. doi: 10.1016/j.nbd.2018.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.01.008</ArticleId><ArticleId IdType="pmc">PMC5890443</ArticleId><ArticleId IdType="pubmed">29341898</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, et al. Transneuronal propagation of pathologic &#x3b1;-synuclein from the gut to the brain models Parkinson&#x2019;s disease. Neuron. 2019;103(4):627&#x2013;641. doi: 10.1016/j.neuron.2019.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.035</ArticleId><ArticleId IdType="pmc">PMC6706297</ArticleId><ArticleId IdType="pubmed">31255487</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JY, et al. Lewy bodies in grafted neurons in subjects with Parkinson&#x2019;s disease suggest host-to-graft disease propagation. Nat Med. 2008;14(5):501&#x2013;503. doi: 10.1038/nm1746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1746</ArticleId><ArticleId IdType="pubmed">18391963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kordower JH, et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson&#x2019;s disease. Nat Med. 2008;14(5):504&#x2013;506. doi: 10.1038/nm1747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1747</ArticleId><ArticleId IdType="pubmed">18391962</ArticleId></ArticleIdList></Reference><Reference><Citation>Angot E, Brundin P. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson&#x2019;s disease. Parkinsonism Relat Disord. 2009;15(Suppl 3):S143&#x2013;S147.</Citation><ArticleIdList><ArticleId IdType="pubmed">20082977</ArticleId></ArticleIdList></Reference><Reference><Citation>Angot E, et al. Are synucleinopathies prion-like disorders? Lancet Neurol. 2010;9(11):1128&#x2013;1138. doi: 10.1016/S1474-4422(10)70213-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70213-1</ArticleId><ArticleId IdType="pubmed">20846907</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao X, et al. Pathological &#x3b1;-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science. 2016;353(6307):aah3374. doi: 10.1126/science.aah3374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aah3374</ArticleId><ArticleId IdType="pmc">PMC5510615</ArticleId><ArticleId IdType="pubmed">27708076</ArticleId></ArticleIdList></Reference><Reference><Citation>Challis C, et al. Gut-seeded &#x3b1;-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020;23(3):327&#x2013;336. doi: 10.1038/s41593-020-0589-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0589-7</ArticleId><ArticleId IdType="pmc">PMC7065967</ArticleId><ArticleId IdType="pubmed">32066981</ArticleId></ArticleIdList></Reference><Reference><Citation>Annerino DM, et al. Parkinson&#x2019;s disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol. 2012;124(5):665&#x2013;680. doi: 10.1007/s00401-012-1040-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1040-2</ArticleId><ArticleId IdType="pmc">PMC3473167</ArticleId><ArticleId IdType="pubmed">22941241</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumuratov AS, et al. Enteric neurons from Parkinson&#x2019;s disease patients display ex vivo aberrations in mitochondrial structure. Sci Rep. 2016;6:33117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5021970</ArticleId><ArticleId IdType="pubmed">27624977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S, et al. Genetics of Parkinson&#x2019;s disease: an introspection of its journey towards precision medicine. Neurobiol Dis. 2020;137:104782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7064061</ArticleId><ArticleId IdType="pubmed">31991247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo YM, et al. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet. 2010;19(9):1633&#x2013;1650. doi: 10.1093/hmg/ddq038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq038</ArticleId><ArticleId IdType="pmc">PMC2850613</ArticleId><ArticleId IdType="pubmed">20106867</ArticleId></ArticleIdList></Reference><Reference><Citation>Colucci M, et al. Intestinal dysmotility and enteric neurochemical changes in a Parkinson&#x2019;s disease rat model. Auton Neurosci. 2012;169(2):77&#x2013;86. doi: 10.1016/j.autneu.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2012.04.005</ArticleId><ArticleId IdType="pubmed">22608184</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donovan SM, et al. Nigral overexpression of &#x3b1;-synuclein in a rat Parkinson&#x2019;s disease model indicates alterations in the enteric nervous system and the gut microbiome. Neurogastroenterol Motil. 2020;32(1):e13726.</Citation><ArticleIdList><ArticleId IdType="pubmed">31576631</ArticleId></ArticleIdList></Reference><Reference><Citation>Horsager J, et al. Brain-first versus body-first Parkinson&#x2019;s disease: a multimodal imaging case-control study. Brain. 2020;143(10):3077&#x2013;3088. doi: 10.1093/brain/awaa238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa238</ArticleId><ArticleId IdType="pubmed">32830221</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhmann C, et al. Management of pain in Parkinson&#x2019;s disease. J Parkinsons Dis. 2020;10(s1):S37&#x2013;S48. doi: 10.3233/JPD-202069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202069</ArticleId><ArticleId IdType="pmc">PMC7592654</ArticleId><ArticleId IdType="pubmed">32568113</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Berge N, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol. 2019;138(4):535&#x2013;550. doi: 10.1007/s00401-019-02040-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02040-w</ArticleId><ArticleId IdType="pmc">PMC6778265</ArticleId><ArticleId IdType="pubmed">31254094</ArticleId></ArticleIdList></Reference><Reference><Citation>Surmeier DJ, et al. Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci. 2017;18(2):101&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5564322</ArticleId><ArticleId IdType="pubmed">28104909</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro RJ, et al. Genetic screening of Alzheimer&#x2019;s disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging. 2010;31(5):725&#x2013;731. doi: 10.1016/j.neurobiolaging.2008.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.06.012</ArticleId><ArticleId IdType="pmc">PMC2850052</ArticleId><ArticleId IdType="pubmed">18667258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson O, et al. Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. J Clin Invest. 2007;117(5):1230&#x2013;1239. doi: 10.1172/JCI30447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI30447</ArticleId><ArticleId IdType="pmc">PMC1847535</ArticleId><ArticleId IdType="pubmed">17431506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton M, Hardy J. The presenilins and Alzheimer&#x2019;s disease. Hum Mol Genet. 1997;6(10):1639&#x2013;1646. doi: 10.1093/hmg/6.10.1639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/6.10.1639</ArticleId><ArticleId IdType="pubmed">9300655</ArticleId></ArticleIdList></Reference><Reference><Citation>Goate A, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer&#x2019;s disease. Nature. 1991;349(6311):704&#x2013;706. doi: 10.1038/349704a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/349704a0</ArticleId><ArticleId IdType="pubmed">1671712</ArticleId></ArticleIdList></Reference><Reference><Citation>DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol Neurodegener. 2019;14(1):32. doi: 10.1186/s13024-019-0333-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0333-5</ArticleId><ArticleId IdType="pmc">PMC6679484</ArticleId><ArticleId IdType="pubmed">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Schliebs R. Basal forebrain cholinergic dysfunction in Alzheimer&#x2019;s disease &#x2014; interrelationship with beta-amyloid, inflammation and neurotrophin signaling. Neurochem Res. 2005;30(6&#x2013;7):895&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">16187224</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang Q, Young HM. Chemical coding of neurons in the myenteric plexus and external muscle of the small and large intestine of the mouse. Cell Tissue Res. 1996;284(1):39&#x2013;53. doi: 10.1007/s004410050565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004410050565</ArticleId><ArticleId IdType="pubmed">8601295</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabal A, et al. beta-Amyloid precursor protein (beta APP) in human gut with special reference to the enteric nervous system. Brain Res Bull. 1995;38(5):417&#x2013;423. doi: 10.1016/0361-9230(95)02006-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0361-9230(95)02006-D</ArticleId><ArticleId IdType="pubmed">8665264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankle WR, et al. Studies of the enteric nervous system in Alzheimer disease and other dementias of the elderly: enteric neurons in Alzheimer disease. Mod Pathol. 1993;6(1):10&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">8426853</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsom EM, et al. Do the bugs in your gut eat your memories? Relationship between gut microbiota and Alzheimer&#x2019;s disease. Brain Sci. 2020;10(11):E814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693835</ArticleId><ArticleId IdType="pubmed">33153085</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabi M, et al. Gut inflammation induced by dextran sulfate sodium exacerbates amyloid-&#x3b2; plaque deposition in the AppNL-G-F mouse model of Alzheimer&#x2019;s disease. J Alzheimers Dis. 2021;79(3):1235&#x2013;1255. doi: 10.3233/JAD-201099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-201099</ArticleId><ArticleId IdType="pmc">PMC8122495</ArticleId><ArticleId IdType="pubmed">33427741</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, et al. Loss of nitrergic and cholinergic neurons in the enteric nervous system of APP/PS1 transgenic mouse model. Neurosci Lett. 2017;642:59&#x2013;65. doi: 10.1016/j.neulet.2017.01.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.01.061</ArticleId><ArticleId IdType="pubmed">28137646</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo AV, et al. Microbiota-derived short chain fatty acids modulate microglia and promote A&#x3b2; plaque deposition. Elife. 2021;10:e59826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043748</ArticleId><ArticleId IdType="pubmed">33845942</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SY, et al. Dementia and vagotomy in Taiwan: a population-based cohort study. BMJ Open. 2018;8(3):e019582. doi: 10.1136/bmjopen-2017-019582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-019582</ArticleId><ArticleId IdType="pmc">PMC5884346</ArticleId><ArticleId IdType="pubmed">29602843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, et al. Intra-gastrointestinal amyloid-&#x3b2;1-42 oligomers perturb enteric function and induce Alzheimer&#x2019;s disease pathology. J Physiol. 2020;598(19):4209&#x2013;4223. doi: 10.1113/JP279919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP279919</ArticleId><ArticleId IdType="pmc">PMC7586845</ArticleId><ArticleId IdType="pubmed">32617993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzi RM, et al. Unsuspected involvement of spinal cord in Alzheimer disease. Front Cell Neurosci. 2020;14:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7002560</ArticleId><ArticleId IdType="pubmed">32082122</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger BN, et al. The distribution of phosphorylated tau in spinal cords of Alzheimer&#x2019;s disease and non-demented individuals. J Alzheimers Dis. 2013;34(2):529&#x2013;536. doi: 10.3233/JAD-121864.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-121864</ArticleId><ArticleId IdType="pmc">PMC3670745</ArticleId><ArticleId IdType="pubmed">23246918</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopoulos PC. Huntington disease: a single-gene degenerative disorder of the striatum. Dialogues Clin Neurosci. 2016;18(1):91&#x2013;98. doi: 10.31887/DCNS.2016.18.1/pnopoulos.</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/DCNS.2016.18.1/pnopoulos</ArticleId><ArticleId IdType="pmc">PMC4826775</ArticleId><ArticleId IdType="pubmed">27069383</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker FO. Huntington&#x2019;s disease. Lancet. 2007;369(9557):218&#x2013;228. doi: 10.1016/S0140-6736(07)60111-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60111-1</ArticleId><ArticleId IdType="pubmed">17240289</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan CM, Raymond LA. Selective neuronal degeneration in Huntington&#x2019;s disease. Curr Top Dev Biol. 2006;75:25&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">16984809</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burg JM, et al. Gastrointestinal dysfunction contributes to weight loss in Huntington&#x2019;s disease mice. Neurobiol Dis. 2011;44(1):1&#x2013;8. doi: 10.1016/j.nbd.2011.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.05.006</ArticleId><ArticleId IdType="pubmed">21624468</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffitt H, et al. Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington&#x2019;s disease. PLoS One. 2009;4(11):e8025. doi: 10.1371/journal.pone.0008025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008025</ArticleId><ArticleId IdType="pmc">PMC2778556</ArticleId><ArticleId IdType="pubmed">19956633</ArticleId></ArticleIdList></Reference><Reference><Citation>McCourt AC, et al. Characterization of gastric mucosa biopsies reveals alterations in Huntington&#x2019;s disease. PLoS Curr. 2015;7:ecurrents. hd.858b4cc7f235df068387e9c20c436a79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4549855</ArticleId><ArticleId IdType="pubmed">26581667</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood NI, et al. Increased thirst and drinking in Huntington&#x2019;s disease and the R6/2 mouse. Brain Res Bull. 2008;76(1&#x2013;2):70&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">18395613</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14(4):248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdewyn S, et al. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice. Mol Neurodegener. 2014;9:24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4088917</ArticleId><ArticleId IdType="pubmed">24938805</ArticleId></ArticleIdList></Reference><Reference><Citation>Anitha M, et al. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest. 2006;116(2):344&#x2013;356. doi: 10.1172/JCI26295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI26295</ArticleId><ArticleId IdType="pmc">PMC1359053</ArticleId><ArticleId IdType="pubmed">16453021</ArticleId></ArticleIdList></Reference><Reference><Citation>Luesma MJ, et al. New insights into c-Ret signalling pathway in the enteric nervous system and its relationship with ALS. Biomed Res Int. 2014;2014:328348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4020535</ArticleId><ArticleId IdType="pubmed">24868525</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, et al. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheperjans F, et al. Gut microbiota are related to Parkinson&#x2019;s disease and clinical phenotype. Mov Disord. 2015;30(3):350&#x2013;358. doi: 10.1002/mds.26069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26069</ArticleId><ArticleId IdType="pubmed">25476529</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam MZ, et al. A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer&#x2019;s disease pathogenicity: an update. CNS Neurol Disord Drug Targets. 2014;13(3):383&#x2013;390. doi: 10.2174/18715273113126660151.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/18715273113126660151</ArticleId><ArticleId IdType="pubmed">24059311</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson TR, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson&#x2019;s disease. Cell. 2016;167(6):1469&#x2013;1480. doi: 10.1016/j.cell.2016.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.018</ArticleId><ArticleId IdType="pmc">PMC5718049</ArticleId><ArticleId IdType="pubmed">27912057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal S, et al. Vagal afferent responses to fatty acids of different chain length in the rat. Am J Physiol Gastrointest Liver Physiol. 2001;281(4):G907&#x2013;G915. doi: 10.1152/ajpgi.2001.281.4.G907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.2001.281.4.G907</ArticleId><ArticleId IdType="pubmed">11557510</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman WJ, et al. Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice. Brain Stimul. 2019;12(1):19&#x2013;29. doi: 10.1016/j.brs.2018.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2018.10.005</ArticleId><ArticleId IdType="pmc">PMC6301148</ArticleId><ArticleId IdType="pubmed">30337243</ArticleId></ArticleIdList></Reference><Reference><Citation>Erny D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18(7):965&#x2013;977. doi: 10.1038/nn.4030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4030</ArticleId><ArticleId IdType="pmc">PMC5528863</ArticleId><ArticleId IdType="pubmed">26030851</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao CM, et al. Sodium butyrate exacerbates parkinson&#x2019;s disease by aggravating neuroinflammation and colonic inflammation in mptp-induced mice model. Neurochem Res. 2020;45(9):2128&#x2013;2142. doi: 10.1007/s11064-020-03074-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-03074-3</ArticleId><ArticleId IdType="pubmed">32556930</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, et al. Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson&#x2019;s disease. Exp Gerontol. 2021;150:111376.</Citation><ArticleIdList><ArticleId IdType="pubmed">33905875</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson TR, et al. A gut bacterial amyloid promotes &#x3b1;-synuclein aggregation and motor impairment in mice. Elife. 2020;9:e53111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012599</ArticleId><ArticleId IdType="pubmed">32043464</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarandi SS, et al. Intestinal bacteria maintain adult enteric nervous system and nitrergic neurons via toll-like receptor 2-induced neurogenesis in mice. Gastroenterology. 2020;159(1):200&#x2013;213. doi: 10.1053/j.gastro.2020.03.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.050</ArticleId><ArticleId IdType="pmc">PMC7387157</ArticleId><ArticleId IdType="pubmed">32234538</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertsalmi TH, et al. Antibiotic exposure and risk of Parkinson&#x2019;s disease in Finland: a nationwide case-control study. Mov Disord. 2020;35(3):431&#x2013;442. doi: 10.1002/mds.27924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27924</ArticleId><ArticleId IdType="pubmed">31737957</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips RJ, et al. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson&#x2019;s disease? Neuroscience. 2008;153(3):733&#x2013;750. doi: 10.1016/j.neuroscience.2008.02.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.02.074</ArticleId><ArticleId IdType="pmc">PMC2605676</ArticleId><ArticleId IdType="pubmed">18407422</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha L, et al. Salmonella infection in chronic inflammation and gastrointestinal cancer. Diseases. 2019;7(1):E28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6473780</ArticleId><ArticleId IdType="pubmed">30857369</ArticleId></ArticleIdList></Reference><Reference><Citation>Koscso B, et al. Gut-resident CX3CR1(hi) macrophages induce tertiary lymphoid structures and IgA response in situ. Sci Immunol. 2020;5(46):eaax0062. doi: 10.1126/sciimmunol.aax0062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aax0062</ArticleId><ArticleId IdType="pmc">PMC7296464</ArticleId><ArticleId IdType="pubmed">32276965</ArticleId></ArticleIdList></Reference><Reference><Citation>Horuluoglu BH, et al. PAM3 protects against DSS-induced colitis by altering the M2:M1 ratio. Sci Rep. 2020;10(1):6078. doi: 10.1038/s41598-020-63143-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-63143-z</ArticleId><ArticleId IdType="pmc">PMC7142137</ArticleId><ArticleId IdType="pubmed">32269253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto Y, et al. Chronic mild gut inflammation accelerates brain neuropathology and motor dysfunction in &#x3b1;-synuclein mutant mice. Neuromolecular Med. 2019;21(3):239&#x2013;249. doi: 10.1007/s12017-019-08539-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-019-08539-5</ArticleId><ArticleId IdType="pmc">PMC6701950</ArticleId><ArticleId IdType="pubmed">31079293</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris EH, et al. Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. Am J Pathol. 2007;170(2):658&#x2013;666. doi: 10.2353/ajpath.2007.060359.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.060359</ArticleId><ArticleId IdType="pmc">PMC1851868</ArticleId><ArticleId IdType="pubmed">17255333</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen LK, et al. A role for viral infections in Parkinson&#x2019;s etiology? Neuronal Signal. 2018;2(2):NS20170166. doi: 10.1042/NS20170166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/NS20170166</ArticleId><ArticleId IdType="pmc">PMC7373231</ArticleId><ArticleId IdType="pubmed">32714585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan QY, et al. Older patients with IBD might have higher risk of Parkinson&#x2019;s disease. Gut. 2020;69(1):193&#x2013;194. doi: 10.1136/gutjnl-2018-317103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2018-317103</ArticleId><ArticleId IdType="pubmed">30518530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirstea MS, et al. Microbiota composition and metabolism are associated with gut function in Parkinson&#x2019;s disease. Mov Disord. 2020;35(7):1208&#x2013;1217. doi: 10.1002/mds.28052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28052</ArticleId><ArticleId IdType="pubmed">32357258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodiya HB, et al. Chronic stress-induced gut dysfunction exacerbates Parkinson&#x2019;s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson&#x2019;s disease. Neurobiol Dis. 2020;135:104352.</Citation><ArticleIdList><ArticleId IdType="pubmed">30579705</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelz JO, et al. Axonal degeneration of the vagus nerve in Parkinson&#x2019;s disease-a high-resolution ultrasound study. Front Neurol. 2018;9:951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240697</ArticleId><ArticleId IdType="pubmed">30483212</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JG, et al. High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment. PLoS One. 2019;14(8):e0217194. doi: 10.1371/journal.pone.0217194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0217194</ArticleId><ArticleId IdType="pmc">PMC6690581</ArticleId><ArticleId IdType="pubmed">31404072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, et al. Fecal microbiota transplantation alleviated Alzheimer&#x2019;s disease-like pathogenesis in APP/PS1 transgenic mice. Transl Psychiatry. 2019;9(1):189. doi: 10.1038/s41398-019-0525-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0525-3</ArticleId><ArticleId IdType="pmc">PMC6683152</ArticleId><ArticleId IdType="pubmed">31383855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MS, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer&#x2019;s disease animal model. Gut. 2020;69(2):283&#x2013;294. doi: 10.1136/gutjnl-2018-317431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2018-317431</ArticleId><ArticleId IdType="pubmed">31471351</ArticleId></ArticleIdList></Reference><Reference><Citation>Raunio A, et al. Lewy-related pathology exhibits two anatomically and genetically distinct progression patterns: a population-based study of Finns aged 85. Acta Neuropathol. 2019;138(5):771&#x2013;782. doi: 10.1007/s00401-019-02071-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02071-3</ArticleId><ArticleId IdType="pmc">PMC6800868</ArticleId><ArticleId IdType="pubmed">31494694</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, et al. New aspects of pathology in Parkinson&#x2019;s disease with concomitant incipient Alzheimer&#x2019;s disease. J Neural Transm Suppl. 1996;48:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8988457</ArticleId></ArticleIdList></Reference><Reference><Citation>Galloway PG, et al. Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol. 1992;140(4):809&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886359</ArticleId><ArticleId IdType="pubmed">1314025</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin JE, et al. Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit. Ann Neurol. 1997;42(4):595&#x2013;603. doi: 10.1002/ana.410420410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420410</ArticleId><ArticleId IdType="pubmed">9382471</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker DG, et al. Changes in properties of serine 129 phosphorylated &#x3b1;-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol. 2013;240:190&#x2013;204. doi: 10.1016/j.expneurol.2012.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.11.020</ArticleId><ArticleId IdType="pmc">PMC3720241</ArticleId><ArticleId IdType="pubmed">23201181</ArticleId></ArticleIdList></Reference><Reference><Citation>Forno LS. Pathology of Parkinson&#x2019;s disease. In: Marsden CD, Fahn S, eds. Movement Disorders. Butterworth-Heinemann; 1981:25&#x2013;40.</Citation></Reference><Reference><Citation>Magrinelli F, et al. Pathophysiology of motor dysfunction in Parkinson&#x2019;s disease as the rationale for drug treatment and rehabilitation. Parkinsons Dis. 2016;2016:9832839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913065</ArticleId><ArticleId IdType="pubmed">27366343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni P, et al. Motor control abnormalities in Parkinson&#x2019;s disease. Cold Spring Harb Perspect Med. 2012;2(6):a009282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3367543</ArticleId><ArticleId IdType="pubmed">22675667</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichter DG, et al. Cognitive and motor dysfunction in Parkinson&#x2019;s disease. Clinical, performance, and computed tomographic correlations. Arch Neurol. 1988;45(8):854&#x2013;860. doi: 10.1001/archneur.1988.00520320040013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1988.00520320040013</ArticleId><ArticleId IdType="pubmed">3293555</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RG, Jahanshahi M. Cognitive-motor dysfunction in Parkinson&#x2019;s disease. Eur Neurol. 1996;36(Suppl 1):24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">8791018</ArticleId></ArticleIdList></Reference><Reference><Citation>Poewe W, et al. Diagnosis and management of Parkinson&#x2019;s disease dementia. Int J Clin Pract. 2008;62(10):1581&#x2013;1587. doi: 10.1111/j.1742-1241.2008.01869.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-1241.2008.01869.x</ArticleId><ArticleId IdType="pmc">PMC2658001</ArticleId><ArticleId IdType="pubmed">18822028</ArticleId></ArticleIdList></Reference><Reference><Citation>Rickards H. Depression in neurological disorders: Parkinson&#x2019;s disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry. 2005;76(Suppl 1):i48&#x2013;i52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1765679</ArticleId><ArticleId IdType="pubmed">15718222</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh L. Depression and Parkinson&#x2019;s disease: current knowledge. Curr Neurol Neurosci Rep. 2013;13(12):409. doi: 10.1007/s11910-013-0409-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-013-0409-5</ArticleId><ArticleId IdType="pmc">PMC4878671</ArticleId><ArticleId IdType="pubmed">24190780</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh K, Bennett G. Parkinson&#x2019;s disease and anxiety. Postgrad Med J. 2001;77(904):89&#x2013;93. doi: 10.1136/pmj.77.904.89.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pmj.77.904.89</ArticleId><ArticleId IdType="pmc">PMC1741918</ArticleId><ArticleId IdType="pubmed">11161073</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ, Marsh L. Anxiety in Parkinson&#x2019;s disease: identification and management. Ther Adv Neurol Disord. 2014;7(1):52&#x2013;59. doi: 10.1177/1756285613495723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756285613495723</ArticleId><ArticleId IdType="pmc">PMC3886380</ArticleId><ArticleId IdType="pubmed">24409202</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrempf W, et al. Sleep disorders in Parkinson&#x2019;s disease. J Parkinsons Dis. 2014;4(2):211&#x2013;221. doi: 10.3233/JPD-130301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-130301</ArticleId><ArticleId IdType="pubmed">24796235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons KE, Pahwa R. The impact and management of nonmotor symptoms of Parkinson&#x2019;s disease. Am J Manag Care. 2011;17(Suppl 12):S308&#x2013;S314.</Citation><ArticleIdList><ArticleId IdType="pubmed">22087551</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacy M. Nonmotor symptoms in Parkinson&#x2019;s disease. Int J Neurosci. 2011;121(Suppl 2):9&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">22035025</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloud LJ, Greene JG. Gastrointestinal features of Parkinson&#x2019;s disease. Curr Neurol Neurosci Rep. 2011;11(4):379&#x2013;384. doi: 10.1007/s11910-011-0204-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-011-0204-0</ArticleId><ArticleId IdType="pubmed">21499704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen QQ, et al. Gut inflammation in association with pathogenesis of Parkinson&#x2019;s disease. Front Mol Neurosci. 2019;12:218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6753187</ArticleId><ArticleId IdType="pubmed">31572126</ArticleId></ArticleIdList></Reference><Reference><Citation>Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson&#x2019;s disease pathogenesis? NPJ Parkinsons Dis. 2017;3:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5445611</ArticleId><ArticleId IdType="pubmed">28649603</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta SK, et al. Parkinson&#x2019;s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation. J Neurogastroenterol Motil. 2019;25(3):363&#x2013;376. doi: 10.5056/jnm19044.</Citation><ArticleIdList><ArticleId IdType="doi">10.5056/jnm19044</ArticleId><ArticleId IdType="pmc">PMC6657920</ArticleId><ArticleId IdType="pubmed">31327219</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma RB, et al. Identifying prodromal Parkinson&#x2019;s disease: pre-motor disorders in Parkinson&#x2019;s disease. Mov Disord. 2012;27(5):617&#x2013;626. doi: 10.1002/mds.24996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.24996</ArticleId><ArticleId IdType="pubmed">22508280</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi A, et al. Hypometabolism in the supplementary and anterior cingulate cortices is related to dysphagia in Parkinson&#x2019;s disease: a cross-sectional and 3-year longitudinal cohort study. BMJ Open. 2013;3(3):e002249. doi: 10.1136/bmjopen-2012-002249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2012-002249</ArticleId><ArticleId IdType="pmc">PMC3612769</ArticleId><ArticleId IdType="pubmed">23457325</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston BT, et al. Swallowing and esophageal function in Parkinson&#x2019;s disease. Am J Gastroenterol. 1995;90(10):1741&#x2013;1746.</Citation><ArticleIdList><ArticleId IdType="pubmed">7572887</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheard JM, et al. Malnutrition in a sample of community-dwelling people with Parkinson&#x2019;s disease. PLoS One. 2013;8(1):e53290. doi: 10.1371/journal.pone.0053290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0053290</ArticleId><ArticleId IdType="pmc">PMC3541272</ArticleId><ArticleId IdType="pubmed">23326408</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsyth CB, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson&#x2019;s disease. PLoS One. 2011;6(12):e28032. doi: 10.1371/journal.pone.0028032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0028032</ArticleId><ArticleId IdType="pmc">PMC3228722</ArticleId><ArticleId IdType="pubmed">22145021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos Bernardes da Silva Filho S, et al. Neuro-degeneration profile of Alzheimer&#x2019;s patients: a brain morphometry study. Neuroimage Clin. 2017;15:15&#x2013;24. doi: 10.1016/j.nicl.2017.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.04.001</ArticleId><ArticleId IdType="pmc">PMC5397580</ArticleId><ArticleId IdType="pubmed">28459000</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, et al. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960&#x2013;969. doi: 10.1097/NEN.0b013e318232a379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318232a379</ArticleId><ArticleId IdType="pubmed">22002422</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiraboschi P, et al. Alzheimer disease without neocortical neurofibrillary tangles: &#x201c;a second look&#x201d;. Neurology. 2004;62(7):1141&#x2013;1147. doi: 10.1212/01.WNL.0000118212.41542.E7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000118212.41542.E7</ArticleId><ArticleId IdType="pubmed">15079014</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers MW, et al. At the interface of sensory and motor dysfunctions and Alzheimer&#x2019;s disease. Alzheimers Dement. 2015;11(1):70&#x2013;98. doi: 10.1016/j.jalz.2014.04.514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.04.514</ArticleId><ArticleId IdType="pmc">PMC4287457</ArticleId><ArticleId IdType="pubmed">25022540</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchman AS, Bennett DA. Loss of motor function in preclinical Alzheimer&#x2019;s disease. Expert Rev Neurother. 2011;11(5):665&#x2013;676. doi: 10.1586/ern.11.57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/ern.11.57</ArticleId><ArticleId IdType="pmc">PMC3121966</ArticleId><ArticleId IdType="pubmed">21539487</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirths O, Bayer TA. Motor impairment in Alzheimer&#x2019;s disease and transgenic Alzheimer&#x2019;s disease mouse models. Genes Brain Behav. 2008;7(Suppl 1):1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18184365</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal NT, et al. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol. 2006;63(12):1763&#x2013;1769. doi: 10.1001/archneur.63.12.1763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.63.12.1763</ArticleId><ArticleId IdType="pubmed">17172617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson RS, et al. The natural history of cognitive decline in Alzheimer&#x2019;s disease. Psychol Aging. 2012;27(4):1008&#x2013;1017. doi: 10.1037/a0029857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0029857</ArticleId><ArticleId IdType="pmc">PMC3534850</ArticleId><ArticleId IdType="pubmed">22946521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley BJ, Petersen RC. Alzheimer&#x2019;s disease and mild cognitive impairment. Neurol Clin. 2007;25(3):577&#x2013;609. doi: 10.1016/j.ncl.2007.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2007.03.008</ArticleId><ArticleId IdType="pmc">PMC2682228</ArticleId><ArticleId IdType="pubmed">17659182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ownby RL, et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530&#x2013;538. doi: 10.1001/archpsyc.63.5.530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.63.5.530</ArticleId><ArticleId IdType="pmc">PMC3530614</ArticleId><ArticleId IdType="pubmed">16651510</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser NC, et al. Differences in anxiety among patients with early- versus late-onset Alzheimer&#x2019;s disease. J Neuropsychiatry Clin Neurosci. 2014;26(1):73&#x2013;80. doi: 10.1176/appi.neuropsych.12100240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.12100240</ArticleId><ArticleId IdType="pubmed">24515678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferretti L, et al. Anxiety and Alzheimer&#x2019;s disease. J Geriatr Psychiatry Neurol. 2001;14(1):52&#x2013;58. doi: 10.1177/089198870101400111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/089198870101400111</ArticleId><ArticleId IdType="pubmed">11281317</ArticleId></ArticleIdList></Reference><Reference><Citation>Teri L, et al. Anxiety of Alzheimer&#x2019;s disease: prevalence, and comorbidity. J Gerontol A Biol Sci Med Sci. 1999;54(7):M348&#x2013;M352. doi: 10.1093/gerona/54.7.M348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/54.7.M348</ArticleId><ArticleId IdType="pubmed">10462166</ArticleId></ArticleIdList></Reference><Reference><Citation>Brzecka A, et al. Sleep disorders associated with Alzheimer&#x2019;s disease: a perspective. Front Neurosci. 2018;12:330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5990625</ArticleId><ArticleId IdType="pubmed">29904334</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliwise DL. Sleep disorders in Alzheimer&#x2019;s disease and other dementias. Clin Cornerstone. 2004;6(Suppl 1A):S16&#x2013;S28.</Citation><ArticleIdList><ArticleId IdType="pubmed">15259536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler CA, et al. The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: mechanisms and pathophysiological role in Alzheimer&#x2019;s disease. Curr Pharm Des. 2016;22(40):6152&#x2013;6166. doi: 10.2174/1381612822666160907093807.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612822666160907093807</ArticleId><ArticleId IdType="pubmed">27604604</ArticleId></ArticleIdList></Reference><Reference><Citation>Secil Y, et al. Dysphagia in Alzheimer&#x2019;s disease. Neurophysiol Clin. 2016;46(3):171&#x2013;178. doi: 10.1016/j.neucli.2015.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2015.12.007</ArticleId><ArticleId IdType="pubmed">26924307</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalski K, Mulak A. Brain-gut-microbiota axis in Alzheimer&#x2019;s disease. J Neurogastroenterol Motil. 2019;25(1):48&#x2013;60. doi: 10.5056/jnm18087.</Citation><ArticleIdList><ArticleId IdType="doi">10.5056/jnm18087</ArticleId><ArticleId IdType="pmc">PMC6326209</ArticleId><ArticleId IdType="pubmed">30646475</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, et al. The gut microbiota and Alzheimer&#x2019;s disease. J Alzheimers Dis. 2017;58(1):1&#x2013;15. doi: 10.3233/JAD-161141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161141</ArticleId><ArticleId IdType="pubmed">28372330</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda M, et al. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer&#x2019;s disease. J Neurol Neurosurg Psychiatry. 2002;73(4):371&#x2013;376. doi: 10.1136/jnnp.73.4.371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.73.4.371</ArticleId><ArticleId IdType="pmc">PMC1738075</ArticleId><ArticleId IdType="pubmed">12235302</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu P, et al. Association of intestinal disorders with Parkinson&#x2019;s disease and Alzheimer&#x2019;s disease: a systematic review and meta-analysis. ACS Chem Neurosci. 2020;11(3):395&#x2013;405. doi: 10.1021/acschemneuro.9b00607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.9b00607</ArticleId><ArticleId IdType="pubmed">31876406</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek N, Newman EJ. Hereditary chorea &#x2014; what else to consider when the Huntington&#x2019;s disease genetics test is negative? Acta Neurol Scand. 2017;135(1):25&#x2013;33. doi: 10.1111/ane.12609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12609</ArticleId><ArticleId IdType="pubmed">27150574</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MA, et al. Motor disorder in Huntington&#x2019;s disease begins as a dysfunction in error feedback control. Nature. 2000;403(6769):544&#x2013;549. doi: 10.1038/35000576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35000576</ArticleId><ArticleId IdType="pmc">PMC2556233</ArticleId><ArticleId IdType="pubmed">10676962</ArticleId></ArticleIdList></Reference><Reference><Citation>Peavy GM, et al. Cognitive and functional decline in Huntington&#x2019;s disease: dementia criteria revisited. Mov Disord. 2010;25(9):1163&#x2013;1169. doi: 10.1002/mds.22953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22953</ArticleId><ArticleId IdType="pmc">PMC2910142</ArticleId><ArticleId IdType="pubmed">20629124</ArticleId></ArticleIdList></Reference><Reference><Citation>Epping EA, Paulsen JS. Depression in the early stages of Huntington disease. Neurodegener Dis Manag. 2011;1(5):407&#x2013;414. doi: 10.2217/nmt.11.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.11.45</ArticleId><ArticleId IdType="pmc">PMC3430381</ArticleId><ArticleId IdType="pubmed">22942903</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale M, van Duijn E. Anxiety in Huntington&#x2019;s disease. J Neuropsychiatry Clin Neurosci. 2015;27(4):262&#x2013;271. doi: 10.1176/appi.neuropsych.14100265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.14100265</ArticleId><ArticleId IdType="pubmed">25803201</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog-Krzywoszanska R, Krzywoszanski L. Sleep disorders in Huntington&#x2019;s disease. Front Psychiatry. 2019;10:221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6474183</ArticleId><ArticleId IdType="pubmed">31031659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnulf I, et al. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol. 2008;65(4):482&#x2013;488. doi: 10.1001/archneur.65.4.482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.4.482</ArticleId><ArticleId IdType="pubmed">18413470</ArticleId></ArticleIdList></Reference><Reference><Citation>Stan TL, et al. Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington&#x2019;s disease. Sci Rep. 2020;10(1):18270. doi: 10.1038/s41598-020-75229-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75229-9</ArticleId><ArticleId IdType="pmc">PMC7589489</ArticleId><ArticleId IdType="pubmed">33106549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagel MC, Leopold NA. Dysphagia in Huntington&#x2019;s disease: a 16-year retrospective. Dysphagia. 1992;7(2):106&#x2013;114. doi: 10.1007/BF02493441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02493441</ArticleId><ArticleId IdType="pubmed">1533361</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M, et al. Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur J Med Res. 1997;2(11):473&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">9385117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Q, et al. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci Rep. 2020;10(1):12998. doi: 10.1038/s41598-020-69845-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69845-8</ArticleId><ArticleId IdType="pmc">PMC7398913</ArticleId><ArticleId IdType="pubmed">32747678</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>